Hui Zhang
- Oncology top 1%
- Immunology top 1%
- Immunotherapy and Immune Responses 16
- Hepatology top 1%
- Cancer Research top 2%
-
- Lung Cancer Treatments and Mutations 37
- Lung Cancer Diagnosis and Treatment 16
-
- Statistical Methods and Bayesian Inference 28
- Statistical Methods and Inference 23
- Statistical Methods in Clinical Trials 18
-
- Childhood Cancer Survivors' Quality of Life 21
-
- Glioma Diagnosis and Treatment 19
- Cited by
- OncologyImmunologyHepatology
- Journals
- Journal of Clinical Oncology (18 papers)Statistical Methods in Medical Research (7 papers)Statistics in Medicine (6 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Hui Zhang
479 papers receiving 11.5k citations
Hit Papers
Peers
Comparison fields: 5 of 223
- Oncology 2.4k
- Immunology 1.8k
- Hepatology 580
- Cancer Research 983
- Pulmonary and Respiratory Medicine 2.0k
Countries citing papers authored by Hui Zhang
This map shows the geographic impact of Hui Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Zhang more than expected).
Fields of papers citing papers by Hui Zhang
This network shows the impact of papers produced by Hui Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Zhang. The network helps show where Hui Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hui Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 11 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 9 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 5 | |
| 9 | 2023 | 33 | |
| 10 | 2023 | 10 | |
| 11 | 2023 | 2 | |
| 12 | 2022 | 1 | |
| 13 | 2021 | 32 | |
| 14 | 2021 | 13 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 7 | |
| 17 | 2015 | 92 | |
| 18 | 2015 | 6 | |
| 19 | 2011 | 26 | |
| 20 | 2003 | 14 |
About Hui Zhang
Hui Zhang is a scholar working on Statistics and Probability, Pulmonary and Respiratory Medicine and Computational Mathematics, having authored 527 papers that have together received 11.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (37 papers), Statistical Methods and Bayesian Inference (28 papers), Statistical Methods and Inference (23 papers), Childhood Cancer Survivors' Quality of Life (21 papers), Glioma Diagnosis and Treatment (19 papers), Statistical Methods in Clinical Trials (18 papers), Immunotherapy and Immune Responses (16 papers) and Lung Cancer Diagnosis and Treatment (16 papers). The work is most often cited by research in Oncology (2.4k citations), Immunology (1.8k citations) and Hepatology (580 citations). Hui Zhang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Douglas Gunzler, Pan Wu, Tian Chen, Fu‐Sheng Wang, Junliang Fu, Ming Shi, Chun‐Bao Zhou, Yongping Yang, Hong Wang and Xun Zhu. Their work appears in journals such as Journal of Clinical Oncology, Statistical Methods in Medical Research, Statistics in Medicine, Journal of Pediatric Psychology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.